PATENT CLAIM ANALYSIS

Application Number: 15995471
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["424", "205100"]

Abstract:
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.

Claim (Index 65):
The method of  claim 63 , wherein the first subject and second subject are human.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.16
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15015322', '15455495', '13260835', '14572004', '12415152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7501968449324846
- 35 USC 102 Novelty (BERT): 0.5621557277874657
- Combined Prediction Score: 0.7313927332179827
- Mean Citation Score: 446.009292
- Max Citation Score: 587.87195
- Similarity Product: 278.9972748049676

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test